about
Selective estrogen receptor modulators (SERMs) for endometriosisAnti-TNF-α treatment for pelvic pain associated with endometriosisPentoxifylline for endometriosisInterventions for women with endometrioma prior to ARTInterventions for women with endometrioma prior to assisted reproductive technologyAnti-TNF-α treatment for pelvic pain associated with endometriosisPentoxifylline versus medical therapies for subfertile women with endometriosisStress exacerbates endometriosis manifestations and inflammatory parameters in an animal model.Endometriosis patients in the postmenopausal period: pre- and postmenopausal factors influencing postmenopausal healthmiR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model.Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility.Endometriosis - morphology, clinical presentations and molecular pathology.A novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model.Managing the misplaced: approach to endometriosis.Asymmetric dimethylarginine (ADMA), nitric oxide metabolite, and estradiol levels in serum and peritoneal fluid in women with endometriosis.CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results.Advances in the management of endometriosis: an update for clinicians.Emerging drugs in endometriosis.Endometriosis: cost estimates and methodological perspective.Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.Prevention of unintended pregnancy and use of contraception-important factors for preconception care.Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis.Dienogest: a new therapeutic agent for the treatment of endometriosis.Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recActivated AKT pathway promotes establishment of endometriosis.Decidualisation of ovarian endometriomas in pregnancy: a management dilemma. A case report and review of the literature.The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent manner.Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.Endometriosis in the north Italian province of South Tyrol.Use of dienogest over 53 weeks for the treatment of endometriosis.Interobserver agreement and accuracy of non-invasive diagnosis of endometriosis by transvaginal sonography.Irritable bowel syndrome and chronic constipation in patients with endometriosis.Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis.Migraine is associated with menorrhagia and endometriosis.Xanthohumol inhibits growth and vascularization of developing endometriotic lesions.Current diagnostic and treatment strategies for adenomyosis
P2860
Q24194214-45268308-BA48-40B6-A84D-90971C4AFE0DQ24198870-5E4586D4-58A6-4599-9262-24FAFE3E8EBAQ24203872-FDACE2EB-12F6-4CF0-B486-3D019D87C1D2Q24234550-8DD092F2-EB9C-4193-AC45-BD51042085CEQ24236483-6CABA459-4CE5-4C58-9B4E-CAFE5D050506Q24236724-AF9BA034-0467-4E61-9364-E840C780906EQ24240064-F83F8BCC-7A93-4198-94F4-EC336AA24EE0Q33714212-5491A86D-A899-4932-BEF4-6A7EDD14E719Q33759318-D1E49D1E-E68D-44AA-8894-BC71BDBA3ADDQ33769100-128BCE34-2D6F-4EB6-ACFB-966048FDFE91Q35127043-F09F2675-C9F0-449D-BFFC-5BBA8FC43303Q35137981-69BD77B6-8DB8-48C8-B295-EAB003DF1244Q35549659-9A2954C6-EC27-432F-B071-75499F8399FCQ35613194-4A160C33-92AC-4861-B585-A05B486BD8EAQ35917599-7C671244-E5EB-4BB8-B8C6-4C6C6926483FQ36105717-3190A383-0181-42FB-A98D-DF6AD5AC5217Q36310331-B753FE8D-3E09-4A19-8425-AEC09783C5D7Q36580603-B7DED01B-5232-4288-8DA6-AF43B4300B48Q36856199-A53F7DF8-7329-4CC4-9FC1-103E9D6EC56FQ37361813-178F918E-F4AE-4508-A7E8-C9F601484DBCQ37397763-CF119D68-FC55-46D9-ACB2-A141EDB2536EQ37558941-0FBF08FE-4850-42E3-9AF4-FC6DC9FAAD8BQ37650643-2D77B33B-39FE-4EB0-A3CD-6F40734F51EBQ37693976-C5FD7DDD-0511-4176-A81D-5DFB60A220EBQ37709202-99D77338-FA29-4F44-ADCF-C76E133A0869Q38275787-2F1E17A3-D5E5-4A54-891B-834B2DF22934Q38800424-7E094DC0-1462-4075-ABAD-10257AD527E3Q39841799-BB4AFA5B-D977-49DF-91FB-291409E573E9Q39930648-83B16056-476A-4E21-87FC-950D65E72C98Q40540901-7BDC95E8-643D-4000-A785-2C8B05080380Q41232648-805722E9-6DCA-485B-AE55-0B5802C2D637Q43310571-CA5C0375-8C50-4C83-AB14-C66E58B69684Q47802440-31199BD2-7721-4C04-8405-DF0A4FD5E202Q48504868-819446FE-6495-40E9-B21D-B771B7C170C8Q54521422-8353D0C5-5060-4679-81CB-1BE27F549D66Q58377151-3263E651-E128-4245-B5B0-E7153D98ED6A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endometriosis: aetiology, pathogenesis and treatment.
@ast
Endometriosis: aetiology, pathogenesis and treatment.
@en
Endometriosis: aetiology, pathogenesis and treatment.
@nl
type
label
Endometriosis: aetiology, pathogenesis and treatment.
@ast
Endometriosis: aetiology, pathogenesis and treatment.
@en
Endometriosis: aetiology, pathogenesis and treatment.
@nl
prefLabel
Endometriosis: aetiology, pathogenesis and treatment.
@ast
Endometriosis: aetiology, pathogenesis and treatment.
@en
Endometriosis: aetiology, pathogenesis and treatment.
@nl
P1433
P1476
Endometriosis: aetiology, pathogenesis and treatment.
@en
P304
P356
10.2165/00003495-200161120-00005
P577
2001-01-01T00:00:00Z
P6179
1012798186